Get started

Codxanalysis

Breaking: Co-Diagnostics, Inc. (CODX) Spike 200% Today Co-Diagnostics, Inc. (NASDAQ: NASDAQ:CODX ) Spike 200% on Monday's market open gaining roughly 225% today. The biochemical company broke out of a falling wedge to reclaim the $1 resistance. Albeit trading in an overbought region as seen with the RSI at 86, NASDAQ:CODX is still gearing for a 3000% move in the near to long term. In another news, Co-Diagnostics announces development of proprietary sample prep Instrument for PoC testing. About CODX Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
NASDAQ:CODXLong
by DEXWireNews
CODX Co Diagnostics SellOff. Buy oportunity?If you missed the 2x from my previews call: Then you should know that the stock was hit by a big selloff, even though they beat the consensus analyst revenue estimate in Q4 with sales being higher 24% year over year to $27.1 million. This might be your 50% upside potential chance. If you are interested to test some amazing BUY and SELL INDICATORS which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:CODXLong
by TopgOptions
4
CODX retracement! Buying opportunity?!Co-Diagnostics Wins Regulatory Approval to Sell COVID-19 Tests in Europe! Nov 17MT Newswires: Co-Diagnostics (CODX) said it has received regulatory authorization to sell its Logix Smart ABC and SARS-CoV-2 multiplex tests for the diagnosis of COVID-19 in markets that accept CE markings. The indicators are looking bullish on lower timeframes, which can mean a trend reversal, but still bearish on higher ones (we don`t have a confirmation of a breakout)! If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:CODXLong
by TopgOptions